Indian generics company Sun Pharma has succeeded in invalidating Otsuka Pharmaceutical’s patent for an injectable, controlled release form of the Japanese drug maker's blockbuster antipsychotic ...

We present a case of an acute dystonic reaction (ADR) following the two-injection start of aripiprazole once-monthly (AOM) in a patient who previously tolerated equivalent doses of oral aripiprazole ...

Abilify is not a controlled substance. It’s an atypical antipsychotic drug. Abilify has some high risk side effects. It also carries boxed warnings, the most serious warnings from the Food and ...

I help businesses solve complex data problems, health economics, budget impact, health policy, real-world, and evidence generation for the pharmaceutical and healthcare industries.

However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...

Two companies that have been blazing a trail in this field are Otsuka Pharmaceutical Company and Proteus Digital Health, with the co-developed Abilify MyCite (aripiprazole tablets with sensor ...

Alvogen Inc.’s proposed generic version of Abilify Maintena infringes six patents for the schizophrenia treatment that an Otsuka Holdings Co. unit exclusively licenses to H. Lundbeck A/S, a federal ...

On Friday, the U.S. Judicial Panel on Multidistrict Litigation ordered nearly 70 lawsuits be coordinated beefore U.S.

Olanzapine, aripiprazole and risperidone are atypical antipsychotics or neuroleptics widely used for schizophrenia treatment. They induce various adverse drug reactions depending on their mechanisms ...

MANILA, Philippines — The Philippine Dermatological Society (PDS) again reminded the public on Monday that injectable glutathione is not approved by local authorities for skin whitening and can ...